99 related articles for article (PubMed ID: 22967555)
21. Expression of endogenous galectin-1 and galectin-3 in intrahepatic cholangiocarcinoma.
Shimonishi T; Miyazaki K; Kono N; Sabit H; Tuneyama K; Harada K; Hirabayashi J; Kasai K; Nakanuma Y
Hum Pathol; 2001 Mar; 32(3):302-10. PubMed ID: 11274640
[TBL] [Abstract][Full Text] [Related]
22. Co-culture of stromal and erythroleukemia cells in a perfused hollow fiber bioreactor system as an in vitro bone marrow model for myeloid leukemia.
Usuludin SB; Cao X; Lim M
Biotechnol Bioeng; 2012 May; 109(5):1248-58. PubMed ID: 22161729
[TBL] [Abstract][Full Text] [Related]
23. Analysis of secreted proteins for the study of bladder cancer cell aggressiveness.
Makridakis M; Roubelakis MG; Bitsika V; Dimuccio V; Samiotaki M; Kossida S; Panayotou G; Coleman J; Candiano G; Anagnou NP; Vlahou A
J Proteome Res; 2010 Jun; 9(6):3243-59. PubMed ID: 20423150
[TBL] [Abstract][Full Text] [Related]
24. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis.
Iguchi T; Aishima S; Taketomi A; Nishihara Y; Fujita N; Sanefuji K; Sugimachi K; Yamashita Y; Maehara Y; Tsuneyoshi M
Hum Pathol; 2009 Feb; 40(2):174-80. PubMed ID: 18835624
[TBL] [Abstract][Full Text] [Related]
25. [Mucinous cholangiocarcinoma, mucus producing carcinoma].
Sakamoto H; Satoh M; Yabana T
Ryoikibetsu Shokogun Shirizu; 1995; (7):414-6. PubMed ID: 8749511
[No Abstract] [Full Text] [Related]
26. Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture.
Scarlett CJ; Saxby AJ; Nielsen A; Bell C; Samra JS; Hugh T; Baxter RC; Smith RC
Hepatology; 2006 Sep; 44(3):658-66. PubMed ID: 16941699
[TBL] [Abstract][Full Text] [Related]
27. Establishment and characterization of cell lines from liver fluke-associated cholangiocarcinoma induced in a hamster model.
Tengchaisri T; Prempracha N; Thamavit W; Boonpucknavig S; Sriurairatana S; Sirisinha S
Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):231-9. PubMed ID: 8629051
[TBL] [Abstract][Full Text] [Related]
28. A novel technique to specifically analyze the secretome of cells and tissues.
Zwickl H; Traxler E; Staettner S; Parzefall W; Grasl-Kraupp B; Karner J; Schulte-Hermann R; Gerner C
Electrophoresis; 2005 Jul; 26(14):2779-85. PubMed ID: 15966010
[TBL] [Abstract][Full Text] [Related]
29. Proteomic analysis of differentially expressed proteins in human cholangiocarcinoma cells treated with Clonorchis sinensis excretory-secretory products.
Pak JH; Moon JH; Hwang SJ; Cho SH; Seo SB; Kim TS
J Cell Biochem; 2009 Dec; 108(6):1376-88. PubMed ID: 19798681
[TBL] [Abstract][Full Text] [Related]
30. Heat shock proteins 27 and 70 are potential biliary markers for the detection of cholangiocarcinoma.
Sato Y; Harada K; Sasaki M; Yasaka T; Nakanuma Y
Am J Pathol; 2012 Jan; 180(1):123-30. PubMed ID: 22051775
[TBL] [Abstract][Full Text] [Related]
31. 2D gel electrophoresis and mass spectrometry identification and analysis of proteins.
Meleady P
Methods Mol Biol; 2011; 784():123-37. PubMed ID: 21898217
[TBL] [Abstract][Full Text] [Related]
32. Pathway-based biomarker search by high-throughput proteomics profiling of secretomes.
Lawlor K; Nazarian A; Lacomis L; Tempst P; Villanueva J
J Proteome Res; 2009 Mar; 8(3):1489-503. PubMed ID: 19199430
[TBL] [Abstract][Full Text] [Related]
33. New miniaturized hollow-fiber bioreactor for in vivo like cell culture, cell expansion, and production of cell-derived products.
Gloeckner H; Lemke HD
Biotechnol Prog; 2001; 17(5):828-31. PubMed ID: 11587570
[TBL] [Abstract][Full Text] [Related]
34. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus.
Sano T; Shimada K; Sakamoto Y; Ojima H; Esaki M; Kosuge T
Ann Surg Oncol; 2008 Feb; 15(2):590-9. PubMed ID: 18057991
[TBL] [Abstract][Full Text] [Related]
35. Histologic bile duct invasion by a mass-forming intrahepatic cholangiocarcinoma.
Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Yamasaki O; Horii K; Kinoshita H
J Hepatobiliary Pancreat Surg; 2002; 9(2):233-6. PubMed ID: 12140612
[TBL] [Abstract][Full Text] [Related]
36. Adenovirus expressing mutant p27kip1 enhanced apoptosis against cholangiocarcinoma than adenovirus-p27kip1 wild type.
Sasaki T; Katayose Y; Suzuki M; Yamamoto K; Shiraso S; Mizuma M; Unno M; Takeuchi H; Lee CT; Matsuno S
Hepatogastroenterology; 2004; 51(55):68-75. PubMed ID: 15011833
[TBL] [Abstract][Full Text] [Related]
37. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.
Lai TC; Chou HC; Chen YW; Lee TR; Chan HT; Shen HH; Lee WT; Lin ST; Lu YC; Wu CL; Chan HL
J Proteome Res; 2010 Mar; 9(3):1302-22. PubMed ID: 20052998
[TBL] [Abstract][Full Text] [Related]
38. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
[TBL] [Abstract][Full Text] [Related]
39. Hilar cholangiocarcinoma evaluated by three-dimensional CT cholangiography and rotating cine cholangiography.
Furukawa H; Sano K; Kosuge T; Shimada K; Yamamoto J; Iwata R; Moriyama N
Hepatogastroenterology; 2000; 47(33):615-20. PubMed ID: 10918998
[TBL] [Abstract][Full Text] [Related]
40. Induction of biliary cholangiocarcinoma cell apoptosis by 103Pd cholangial radioactive stent gamma-rays.
He GJ; Sun DD; Ji DW; Sui DM; Yu FQ; Gao QY; Dai XW; Gao H; Jiang T; Dai CL
Chin Med J (Engl); 2008 Jun; 121(11):1020-4. PubMed ID: 18706251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
